K M Venkat Narayan Selected Research

Prediabetic State (Prediabetes)

1/2022	Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis.
4/2021	Moderate-to-vigorous physical activity changes in a diabetes prevention intervention randomized trial among South Asians with prediabetes - The D-CLIP trial.
3/2020	Clinical utility of 30-min plasma glucose for prediction of type 2 diabetes among people with prediabetes: Ancillary analysis of the diabetes community lifestyle improvement program.
1/2020	Incidence of diabetes and prediabetes and predictors of glycemic change among South Asians in the USA: the MASALA study.
2/2019	Dietary changes in a diabetes prevention intervention among people with prediabetes: the Diabetes Community Lifestyle Improvement Program trial.
1/2018	Global Diabetes Prevention Interventions: A Systematic Review and Network Meta-analysis of the Real-World Impact on Incidence, Weight, and Glucose.
10/2016	The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial.
11/2015	High burden of prediabetes and diabetes in three large cities in South Asia: The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study.
10/2015	Recruitment challenges in a diabetes prevention trial in a low- and middle-income setting.
7/2015	Comparing Type 2 Diabetes, Prediabetes, and Their Associated Risk Factors in Asian Indians in India and in the U.S.: The CARRS and MASALA Studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K M Venkat Narayan Research Topics

Disease

28	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2003
21	Prediabetic State (Prediabetes) 01/2022 - 03/2003
20	Obesity 10/2022 - 01/2007
18	Hypertension (High Blood Pressure) 11/2020 - 03/2002
17	Glucose Intolerance 01/2020 - 03/2003
13	Overweight 12/2021 - 08/2002
12	Insulin Resistance 01/2022 - 07/2007
9	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 03/2002
6	Albuminuria 07/2015 - 03/2002
6	Human Influenza (Influenza) 04/2007 - 06/2004
5	Weight Loss (Weight Reduction) 11/2019 - 01/2003
4	Stroke (Strokes) 01/2021 - 01/2015
4	Hyperglycemia 08/2015 - 05/2010
3	Diabetes Mellitus 01/2022 - 07/2007
3	Inflammation (Inflammations) 01/2022 - 12/2021
3	Myocardial Infarction 01/2021 - 02/2012
3	Chronic Disease (Chronic Diseases) 01/2021 - 04/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 09/2008
3	Dyslipidemias (Dyslipidemia) 01/2020 - 07/2007
3	Abdominal Obesity 09/2016 - 09/2011
3	Proteinuria 04/2007 - 03/2002
2	Neoplasms (Cancer) 01/2022 - 12/2012
2	COVID-19 01/2021 - 06/2020
2	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2018 - 10/2015
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2015
2	Chronic Renal Insufficiency 01/2017 - 01/2015
2	Body Weight (Weight, Body) 03/2016 - 12/2009
2	Noncommunicable Diseases 09/2014 - 02/2008
2	Macular Degeneration (Age-Related Maculopathy) 07/2007 - 07/2007
2	Hypotension (Low Blood Pressure) 04/2006 - 04/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Hypokalemia 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Anemia 01/2020
1	Diabetes Complications 01/2019
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2017

Drug/Important Bio-Agent (IBA)

41	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2002
14	Insulin (Novolin)FDA Link 01/2022 - 08/2006
13	CholesterolIBA 10/2022 - 04/2002
10	LipidsIBA 12/2021 - 06/2004
10	Triglycerides (Triacylglycerol)IBA 05/2017 - 07/2007
9	HDL CholesterolIBA 05/2017 - 07/2007
7	LDL CholesterolIBA 01/2020 - 04/2002
5	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2013
5	CreatinineIBA 07/2015 - 03/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2007 - 06/2004
4	Metformin (Glucophage)FDA LinkGeneric 10/2016 - 12/2009
4	Blood Glucose (Blood Sugar)IBA 03/2016 - 01/2003
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2016 - 01/2003
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 06/2004
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 04/2007
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 05/2010
3	AntioxidantsIBA 01/2017 - 07/2007
3	HDL LipoproteinsIBA 01/2017 - 05/2010
3	Biological ProductsIBA 02/2016 - 07/2008
3	Pharmaceutical PreparationsIBA 11/2015 - 05/2010
3	AdiponectinIBA 10/2015 - 05/2010
3	AlbuminsIBA 01/2015 - 12/2008
3	C-Reactive ProteinIBA 10/2013 - 05/2010
2	CytokinesIBA 01/2022 - 10/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 04/2017
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 03/2013 - 06/2004
2	VitaminsIBA 07/2007 - 07/2007
2	Lipoproteins (Lipoprotein)IBA 04/2006 - 04/2002
1	Cholesterol Esters (Cholesteryl Esters)IBA 10/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 12/2021
1	SugarsIBA 12/2021
1	Guanosine Diphosphate (GDP)IBA 12/2021
1	Guanine NucleotidesIBA 10/2021
1	CytosineIBA 10/2021
1	Biological FactorsIBA 01/2021
1	Particulate MatterIBA 10/2020
1	NexusIBA 06/2020
1	LeptinIBA 01/2020
1	DiureticsIBA 01/2020
1	MicronutrientsIBA 01/2020
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2020
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 12/2019
1	DDTIBA 12/2019
1	PesticidesIBA 12/2019
1	Potassium Iodide (Pima)FDA Link 11/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	hydroxide ionIBA 05/2018
1	25-hydroxyvitamin DIBA 05/2018
1	Vitamin D FDA LinkGeneric 05/2018

Therapy/Procedure

8	Glycemic Control 01/2021 - 04/2002
5	Therapeutics 01/2020 - 08/2006
4	Surgical Instruments (Clip) 04/2021 - 04/2012
2	Surgical Amputation (Amputations) 01/2021 - 06/2004
2	Ambulatory Care (Outpatient Care) 03/2015 - 12/2012
1	Continuity of Patient Care 11/2020
1	Complementary Therapies (Alternative Medicine) 12/2017
1	Bariatric Surgery 12/2017